Sebaceous carcinoma usually occurs in adults older than 60 years, on the eyelid, head and
neck, and trunk. In this Review, we present clinical care recommendations for sebaceous …

Abstract Purpose of Review The therapeutic landscape for non-melanoma skin cancer
(NMSC) has recently expanded with the development of effective and targeted …

Background Low-density lipoprotein receptor-related protein 1b (encoded by LRP1B) is a
putative tumor suppressor, and preliminary evidence suggests LRP1B-mutated cancers may …

As the incidence of cutaneous malignancies continues to rise and their treatment with
immunotherapy expands, dermatologists and their patients are more likely to encounter …

The treatment of bone metastases is a thorny issue. Immunotherapy may be one of the few
hopes for patients with unresectable bone metastases. Immune checkpoint inhibitors are the …

Nonmelanoma skin cancer (NMSC) is the most frequently diagnosed malignancy in
humans, representing a broad range of cutaneous tumors. Keratinocyte carcinomas …

Sebaceous carcinoma (SC) is a very rare and aggressive form of skin cancer that arises
from the sebaceous glands. SC can occur anywhere on the body, but most commonly affects …

Nonmelanoma skin cancers (NMSCs) are some of the most commonly diagnosed
malignancies. In general, early-stage NMSCs have favorable outcomes; however, a small …

Background The combination of immune checkpoint inhibitors (ICIs) and chemotherapy has
been the standard first-line treatment for advanced non-small cell lung cancer (NSCLC) …

Non-melanoma skin cancers (NMSCs), which represent a diverse group of cutaneous
malignancies, are the most common forms of human neoplasia. The incidence of these …